Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Professor's little helper

The use of cognitive-enhancing drugs by both ill and healthy individuals raises ethical questions that should not be ignored, argue Barbara Sahakian and Sharon Morein-Zamir.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Comas-Herrera, A., Wittenberg, R., Pickard, L., Knapp, M. & MRC-CFAS. PSSRU Discussion Paper 1728 (2003).

  2. Wu, E. Q. et al. J. Clin. Psychiatry 66, 1122–1129 (2005).

    Article  Google Scholar 

  3. Davidson, M. & Keefe, R. S. Schizophr. Res. 17, 123–129 (1995).

    Article  CAS  Google Scholar 

  4. Morein-Zamir, S., Turner, D. C. & Sahakian, B. J. Schizophr. Bull. doi:10.1093/schbul/sbm090 (2007).

  5. Turner, D. C. et al. Neuropsychopharmacol. 29, 1363–1373 (2004).

    Article  CAS  Google Scholar 

  6. Barkley, R. A. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment 3rd edn (Guilford, New York, 2006).

    Google Scholar 

  7. Swanson, J. M. et al. J. Am. Acad. Child Adolesc. Psychiatry 46, 1015–1027 (2007).

    Article  Google Scholar 

  8. Farah, M. J. et al. Nature Rev. Neurosci. 5, 421–425 (2004).

    Article  CAS  Google Scholar 

  9. Lorist, M. M. & Tops, M. Brain Cogn. 53, 82–94 (2003).

    Article  Google Scholar 

  10. Elliott, R. et al. Psychopharmacol. 131, 196–206 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

Barbara Sahakian consults for several pharmaceutical companies and for Cambridge Cognition. She also has shares in CeNeS.

Additional information

Join the discussion at: http://network.nature.com/forums/naturenewsandopinion/816

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sahakian, B., Morein-Zamir, S. Professor's little helper. Nature 450, 1157–1159 (2007). https://doi.org/10.1038/4501157a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/4501157a

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing